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Abstract 
 
Habitual Aerobic Exercise and Smoking-associated Arterial Stiffening 
 
Wonil Park, M.S. Kin 
The University of Texas at Austin, 2014 
 
Supervisor: Hirofumi Tanaka 
 
The largest percentage of mortality from tobacco smoking is cardiovascular-
related. It is not known whether regular participation in exercise mitigates the adverse 
influence of smoking on vasculature. The purpose of this study is to determine if regular 
aerobic exercise is associated with reduced arterial stiffness in young men who are 
cigarette smokers. Using a cross-sectional observational study design, the sample 
included 78 young men (22±5 years) with the following classification: sedentary smokers 
(n=12); physically active smokers (n=25); sedentary non-smokers (n=20); and physically 
active non-smokers (n=21). Arterial stiffness was assessed by brachial-ankle pulse wave 
velocity (baPWV). There were no group differences in height, body fatness, systolic and 
diastolic blood pressure. As expected, both physically active groups demonstrated greater 
VO2max and lower heart rate at rest than their sedentary peers. The sedentary smokers 
demonstrated greater baPWV than the sedentary non-smokers (1,183±33.5 vs. 1,055±25 
cm/sec). baPWV was not different between the physically-active smokers and the 
physically-active non-smokers (1,084±26 vs. 1,070±28.6 cm/sec). Chronic smoking is 
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associated with arterial stiffening in sedentary men but a significant smoking-induced 
increase in arterial stiffness was not observed in physically active adults.  These results 
are consistent with the idea that regular participation in physical activity may mitigate the 
adverse effect of smoking on the vasculature. 
 
 vi 
Table of Contents 
List of Tables  ..................................................................................................... viii 
List of Figures  ...................................................................................................... ix 
Chapter 1  Introduction  ........................................................................................1 
1.1 Background  .............................................................................................1 
1.2 Statement of purpose ...............................................................................3 
1.3 Hypothesis ...............................................................................................4 
Chapter 2  Review of the Literature  .....................................................................5 
2.1 Tobacco-related mortality  .......................................................................5 
2.2 Cigarette smoking and cardiovascular disease  .......................................6 
2.3 Cigarette smoking and arterial stiffness ....................................................9 
2.4 Cigarette smoking and exercise  ............................................................11 
2.5 Exercise and arterial stiffness  ...............................................................13 
2.6 Smoking cessation  ................................................................................14 
2.7 Exercise and smoking cessation ............................................................15 
Chapter 3  Methodology  ....................................................................................17 
3.1 Subjects  .................................................................................................17 
3.2 Experimental Procedures  ......................................................................18 
Body composition assessment  ...........................................................18 
Blood pressure  ...................................................................................18 
Arterial stiffness  .................................................................................18 
Maximal oxygen consumption  ...........................................................19 
3.3 Statistical analysis  .................................................................................20 
 
Chapter 4 Results  .................................................................................................21 
4.1 Selected physical characteristics, blood pressure, and PWV  ................21 
 vii 
Chapter 5 Discussion  ...........................................................................................25 
Chapter 6 Limitations and Implications  ...............................................................28 
Chapter 7 Conclusion  ...........................................................................................29 
Appendix A  Informed Consent Form  ...............................................................30 
Appendix B  Health research questionnaire  .......................................................34 
Appendix C  Smoking Quesionnaire  .................................................................40 
Appendix D  Physical activity during one week  ................................................41 
Appendix E  General questionnaire   .................................................................42 
Appendix F  Godin Leisure-Time Exercise Questionnaire ................................43 
References  ............................................................................................................45 
 viii 
List of Tables 
Table 1: Selected Subject Charateristics in 4 groups  ..........................................22 
Table 2: Heart rate and blood pressure at rest in 4 groups  ..................................23 
 
 ix 
List of Figures 
Figure 1: Bar graph of brachial-ankle PWV at rest is compared among sedentary non-
smokers, sedentary smokers, active non-smokers, and active smokers by 
analysis of variance  ...........................................................................24 
  
 1 
CHAPTER 1  
INTRODUCTION 
 
1.1 Background 
Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in 
the United States and results in 40% of all-cause mortality in developed countries. CVD 
is caused by non-modifiable risk factors (e.g. genetic predisposition, age, and gender) as 
well as those that can be modified by lifestyle intervention such as diet, exercise, and 
smoking cessation (Campbell et al. 2008). Cigarette smoking is one of the most 
preventable risk factors for CVD (Rhee et al. 2007). Despite progress in reducing the 
prevalence of cigarette smoking, tobacco remains as one of the most important public 
health burdens (Ng et al. 2014).  The effect of smoking on CVD appears to be mediated, 
at least in part, by arterial stiffening (Rhee et al. 2007). Both blood pressure (BP) and 
carotid-femoral PWV are increased significantly after acute smoking (Mahmud & Felly. 
2003; Rhee et al. 2007; Scallan et al. 2010), and chronic smoking is associated with 
increasing arterial stiffness (Xing & Wang. 2004; Kim et al, 2005). 
Increasing physical activity is a potential strategy that can reduce harmful effects 
of chronic smoking (Tanaka & Safar. 2005). However, it is not known whether regular 
exercise mitigates the adverse effects of smoking on large artery distensibility.  The 
primary aim of this study was to determine if smokers who perform regular aerobic 
exercise demonstrate lower arterial stiffness than their sedentary peers.  To do so, we 
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measured pulse wave velocity, a measure of arterial stiffness, in non-smoking control 
groups and groups of smokers who were either physically active or not.  Even though 
the majority of smokers remain sedentary (Conway & Cronan. 1992; Deruiter et al. 
2008), the proportion of chronic smokers who perform regular physical activity is 
surprisingly high comprising almost one quarter of the entire smoking population 
(Deruiter et al. 2008).  We reasoned that the potentially important message would arise 
from this study for chronic smokers who remain physically active in spite of repeated 
attempts to quit smoking. 
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1.2 Statement of purpose 
The purpose of the present investigation was to determine if regular aerobic 
exercise is associated with reduced arterial stiffness in cigarette smoking. The specific 
objectives of the study were to: 
 
1. Determine habitual aerobic exercise effects on arterial stiffening. 
2. Determine smoking habit effects on arterial stiffening. 
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1.3 Hypothesis 
In the current study, we tested the following hypotheses: 
 
1. Reduction on vascular function would be greater in sedentary smokers 
compared with physically active smokers. 
2. Regular aerobic exercise reduces the effects of smoking on the vasculature. 
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CHAPTER 2  
LITERATURE REVIEW 
 
 
This literature review summarizes the relevant research that shows habitual 
aerobic exercise mitigates cigarette smoking-associated arterial stiffening. The topics in 
this review of literature include cigarette smoking, arterial stiffness as it relates to 
cardiovascular diseases, the evidence of arterial stiffness in healthy young men, and the 
use of pulse wave velocity to assess arterial stiffness. 
 
2.1 Tobacco-related mortality 
Smoking causes many diseases and reduces quality of life and life expectancy 
(CDC. 2013). The World Health Organization Framework Convention on Tobacco 
Control indicates that tobacco has a harmful effect on our body and its’ use needs to be 
prevented (WHO. 2013). In the United States, one in every five deaths is caused by 
cigarette smoking each year, and more than 480,000 people die from smoking cigarette 
(CDC.2013; MMWR. 2013). Approximately 6 million people die and more than half a 
trillion dollars of economic loss is caused by tobacco in the world (WHO. 2013). Both 
male and female middle-aged smokers have three times higher overall mortality than age-
matched non-smokers (CDC. 2013). Life expectancy is at least 10 years shorter in 
smokers than nonsmokers (Jha et al. 2013). However, smoking cessation before the age 
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of 40 can reduce the estimated number of overall mortality related to smoking-related 
diseases (Villablanca et al. 2000; CDC. 2013). 
In addition to the first-hand smoke, exposure to second-hand smoke causes 
serious health problems such as cardiovascular disease, respiratory disease, and lung 
cancer (CDC. 2013). Second-hand smoking results in approximately 42,000 deaths each 
year among adults in the United States (USDHHS. 2014). The annual smoking-related 
mortality is expected to remain high for decades into the future. One particular concern of 
this is that youth and young adults demonstrate consistently high levels of prevalence of 
current smoking and initiation (USDHHS. 2014). 
 
2.2 Cigarette smoking and cardiovascular disease 
For the past 80 years, cardiovascular disease (CVD) has been the leading cause 
of mortality and morbidity in the United States and is the cause of more than 800,000 
deaths annually, and results in 40% of all-cause of mortality in developed countries 
(WHO. 2013; CDC. 2013; Freeman et al. 2014). Cigarette smoking is consistently 
associated with increased CVD compared with nonsmokers (Campbell et al. 2008). 
Nearly one-fifth of deaths from CVD are attributable to smoking (USDHHS. 2014). 
Smoking is one of the major, preventable, and independent risk factors for CVD, 
including myocardial infarction, angina pectoris, stroke, heart failure, atrial fibrillation, 
and peripheral arterial disease (Villablanca et al. 2000). Current estimates for the United 
States are that 25.9 million men (27.8%) and 23.5 million women (23.3%) are smokers, 
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putting them at increased risk of heart attack (CDC. 2013). Cigarette Smoking increases 
the risk of dying from coronary heart disease among middle-aged men and women by 4 
and 5 times, respectively. Second-hand smoking causes 33,951 annual deaths from heart 
disease (USDHHS, 2014). Differences potentially exist between males and females with 
smoking and the incidence of CVD. Even though both men and women smoked the same 
amount of cigarettes, women have twice the risk of CVD compared with men (Carpenter 
et al. 2006). This has been attributed to the hormonal difference between genders 
(Campbell et al. 2008). 
Tobacco is a complex mixture of more than 4,000 chemical components, in 
addition to tar and nicotine. Because of the complexity of smoke, pathophysiologic 
relationships and mechanisms with smoking were difficult to mediate and elucidate 
(Villablanca et al. 2000). Although many studies are in progress, further studies are 
warranted to better understand the cardiovascular responses and other consequences in 
cigarette smoking and second-hand smoke exposure (Masironi & Chiba. 1992). One 
previous study showed that chronic smoke exposure in rats demonstrated significant 
cardiovascular effects, but acute nicotine infusion in the rat did not alter cardiovascular 
responses during chronic smoke exposure (Barron et al. 1988). 
There are many of the constituents in blood, including white blood cells and 
platelets, those are changed upon exposure to cigarette smoking (Villablanca et al. 2000). 
Smoking leads to an increase in white blood cells due to an increase in the number of 
peripheral blood neutrophils (Barbour et al. 1997). Smoking even a few cigarettes 
activates leukocytes (Blann et al. 1998). Activation of neutrophils may increase the 
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development of cardiovascular disease. This is because neutrophils cause an increase in 
oxygen-derived free radicals or elastases, which may deteriorate the endothelium and 
vessel wall, and promote the progression and development of atherosclerosis (Villablanca 
et al. 2000). Therefore, these hematological changes hasten thrombus formation, which 
may result in myocardial infarction in patients with and without coronary atherosclerosis. 
Overall, lipoproteins have an important role in the shuttling of triglycerides and 
cholesterol in the blood, and maintain homeostasis of lipids in the body. Smoking leads to 
lipid and lipoprotein abnormalities that smokers had an increase in low-density 
lipoprotein (LDL) and a decrease high-density lipoprotein (HDL) compared with 
nonsmokers (Freeman & Packard. 1995). Furthermore, elevated cholesterol concentration 
in smokers shows an increased risk of coronary artery disease (Blann et al. 1998; 
Chignard. 1993). In particular, elevated LDL by cigarette smoking has been linked to the 
initiation and progression of atherosclerosis (Villablanca et al. 2000).  
Therefore, Cigarette smoking is a strong risk factor for cardiovascular disease in 
both men and women. The pathophysiological mechanisms between smoking and 
cardiovascular disease that are responsible for smoking-related vascular damage include 
changes in hemostatic factors, endothelial function, and blood lipids. However, because 
of the complexity of interactions between the different components of cigarettes, more 
studies are needed to investigate the relation of cardiovascular disease to cigarette 
smoking. 
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2.3 Cigarette smoking and arterial stiffness 
The large and medium-sized arteries in the cardiovascular system play an 
important role in the delivery of blood flow to peripheral arteries. The elastic properties 
of these vessels allow for the smoothing of oscillations in blood pressure (BP), reduction 
of pulse pressure (PP), and perfusion of the myocardium (Vlachopoulos et al. 2004). 
These properties are all dependent on the arterial stiffness, which determines the velocity 
of incident and reflected traveling pressure wave (Mahmud & Feely, 2003; Scallan. Et al.  
2010). 
Noninvasive measurements and techniques (e.g., ultrasound, Doppler, 
applanation tonometry, and echo-tracking) have been developed and used widely to 
measure arterial stiffness (Kim et al. 2005; Doonan et al. 2011; Kawabata et al. 2012). To 
date, pulse wave velocity (PWV) has been used as a simple, noninvasive, and 
reproducible measurement of arterial stiffness. PWV is a measure of the traveled distance 
divided by the total time for the wave to travel distance [PWV = distance (m)/transit time 
(s)] (Scallan et al. 2010). PWV can be measured between two sites a known distance 
apart, and represents the arterial stiffness in the vascular tree. The stiffer the artery is, the 
faster the pressure wave moves through artery and the extent to which the arterial wave is 
applied from the periphery (Mahmud & Feely. 2003; Kim et al. 2005). 
Carotid-femoral PWV (cfPWV) is the recognized “gold-standard measurement” 
of arterial stiffness. Increased pulse wave velocity (PWV) can lead to the reflected wave 
arriving at the heart during late systole to diastole in normal conditions (Kim et al. 2005). 
This rapid return of the reflected wave increases systolic pressure causing an elevation of 
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afterload on the heart with a potential effect on left ventricular hypertrophy and 
stiffening. In addition, diastolic pressure decreases, which may reduce coronary perfusion 
and increase ischemia. Previous studies show that PWV reflects age-related changes in 
vascular stiffness (Kim et al. 2005; Scallan et al. 2010). Functional change in the arterial 
response to pulsatile pressure associated with impaired compliances of vessels can 
increase atherosclerosis and vascular damages. 
Arterial stiffness is increasingly being recognized as an important cardiovascular 
risk factor and an independent predictor of all-cause and cardiovascular death rate 
(Nurnberger et al. 2003). Acute smoking and chronic smoking lead to increased arterial 
stiffness in several studies (Kim et al. 2005; Raymond et al. 2012; Scallan et al. 2010; 
Rhee et al. 2007). For example, acute smoking significantly increased both blood 
pressure and cfPWV (Mahmud & Feely. 2003) and significantly increases both arterial 
stiffness (e.g. cfPWV, baPWV) and BP in chronic smokers (Mahmud & Feely. 2003; 
Kim et al. 2005; Rhee et al. 2007).  Cigarette smoking changes both central and 
peripheral vascular function in all aged smokers. Impaired Flow-mediated dilation 
(FMD) was present in subjects who have systolic blood pressure (SBP) <120mmHg due 
to cigarette smoking (Jatoi et al. 2007). Smoking has been reported to reduce arterial 
distensibility in both large and medium arteries (Vlachopoulos et al. 2004). Acute 
smoking in healthy smokers has demonstrated acute changes of arterial stiffness and 
blood pressure. Smokers have deteriorative arterial stiffness than nonsmokers, and 
chronic smoking can certainly increase arterial stiffness (Kim et al. 2005). 
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Mechanisms underlying elevated arterial stiffness by acute smoking may include 
endothelial dysfunction, enhanced platelet, impaired nitric oxide synthase (NOS) activity, 
increased inflammation, decreased kidney function, insulin resistance, and changes in 
prosyacyclin and vasopressin levels (Rehill et al. 2006). Chronic smokers have a 
decreased NOS activity and an increased oxidative stress; those factors inducing lower 
NO bioavailability (Kim et al. 2005; Rehill et al. 2006; Doonan et al. 2011). Increased 
calcification also plays an important role in contributing to chronic changes in arterial 
stiffness (Scallan et al. 2010). Thus, smoking worsens arterial stiffness presumably 
through both lower NO activity and worse vascular walls. 
 
2.4 Cigarette smoking and exercise 
Smokers may be less likely to perform regular exercise than nonsmokers 
(Deruiter et al. 2008). Smoking is associated with a decrease in the ability to perform 
vigorous exercise because of decreased lung function, increased blood levels of carboxy-
hemoglobin, a blunted heart rate response to exercise, and decreased maximal oxygen 
consumption (Boudreaux et al. 2003). Smokers participate in a lesser amount of vigorous 
activity than nonsmokers, but the difference for moderate or low intensity activities was 
not affected (Kaczynski et al. 2008). Several studies indicate that smoking results in 
lower physical fitness levels even among relatively young and fit military personnel 
(Ward et al. 2002; Dhaliwal et al. 2013; Conway & Cronan. 1992). That means that lower 
 12 
physical fitness levels in smokers is not attributed to less exercise, rather smoking has a 
detrimental effect on physical fitness (Conway & Cronan. 1992).  
Although the relation between smoking and physical inactivity has been studied 
diversely (Ward et al. 2002; Dhaliwal et al. 2013; Conway & Cronan. 1992; Boudreaux 
et al. 2003), we are unaware of how these two risk factors are related in individuals. A 
recent study suggests that physical activity can act as a potential tobacco harm-reducing 
strategy for smokers. Improved arterial compliance has been observed in physically 
active individuals (Tanaka & Safar. 2005). Data from the Cooper Institute for Aerobics 
Research has shown that smokers who maintain a strenuous level of physical fitness have 
lower death rates from all causes than lower fitness non-smokers (Blair et al. 1996).  
Smoking in healthy individuals shows harmful effects on vascular function, 
affecting the ability of the vascular bed to respond to acute exercise (Doonan et al. 2011). 
Cigar smoking increases acute detrimental effect on arterial stiffness in healthy 
individuals who smoked one cigarette during the test (Vlachopoulos. 2004). Particularly, 
occasional cigarette smoking can lead to chronic attenuation of arterial function in 
healthy young individuals (Stoner et al. 2008). Exposure to environmental tobacco smoke 
also plays a role in increased aortic wave reflection and impaired micro-vascular function 
(Argacha et al. 2008). Chronic smokers who engage regularly in aerobic exercise have a 
reduced incidence of developing cardiovascular disease (Doonan et al. 2011). 
Physically active females have a better arterial compliance. For example, 
sedentary healthy females have an age-related central arterial stiffness, but this is not 
observed in physically active women (Tanaka et al. 1998). A cross-sectional study also 
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shows that habitual aerobic exercise in smokers increases peripheral blood flow and 
decreases peripheral vascular resistance (Anton et al. 2006). Therefore, understanding the 
effects of exercise on arterial stiffness is important in reducing cardiovascular disease 
related cigarette smoking. This is because regular exercise decreases the effects of 
chronic smoking on vascular structures, which have a cardio-protective effect. 
 
2.5 Exercise and arterial stiffness 
Lifestyle modifications, in particular aerobic (but not resistance) exercise and 
sodium restriction, are clinically efficient interventions for preventing and alleviating 
arterial stiffening (Tanaka & Safar. 2005). Exercise that decreases the age-related 
increase in arterial stiffness may have the potential to improve outcomes including 
increased cardiovascular risk factors (Ferreira et al. 2002). There are the mechanisms 
underlying the observed effect of exercise on vascular trees. In general, acute exercise 
results in a remodeling of blood flow to the working muscles caused by vasodilation of 
working muscles and vasoconstriction in other organs such as the splanchnic circulation. 
Exercise can trigger by an increase release of endothelin-1 (ET-1) and nitric oxide (NO), 
which mediate blood flow redistribution during exercise (Edwards et al. 2012). In an 
animal study, local ET-1 increases in the splanchnic circulation and decreases in the 
coronary circulation, and NO production increases in the coronary circulation during 
exercise (Kim et al. 2005; Argacha et al. 2008). 
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A recent study has shown a positive effect of exercise on arterial health including 
arterial stiffness, endothelial function, and intima-media thickness in adults (Seals et al. 
2008). Several studies have demonstrated that physical activity reduces systemic blood 
pressure and improves arterial stiffness in children (Farpour-Lambert et al. 2009; 
Sakuragi et al. 2009). Exercise training studies demonstrate that physically active 
individuals have reduced arterial stiffness compared with their sedentary counterparts 
(Boreham et al. 2004; Ferreira et al. 2002). Therefore, exercise-related ameliorations in 
arterial stiffness could be mediated by concurrent improvements on endothelial function, 
inflammation, and sympathetic activity. However, the evidence for a protective effect of 
exercise on arterial stiffness is poorly studied in humans, the mechanisms underlying the 
effect of regular exercise on arterial stiffness need to be elucidated. 
 
2.6 Smoking cessation 
Smoking cessation is one of the most important lifestyle modifications to 
improve health and well-being. Stopping smoking prolongs life and reduces morbidity 
(USDHHS. 2014; Ussher et al. 2012). People who stop smoking decrease their risk of 
cancer, heart disease, stroke, and early death (Jatoi et al. 2007). Smoking cessation can 
decrease the incidence of CVD and acute myocardial infarction (Campbell et al. 2008) 
and may delay the atherosclerosis by 10 years compared to individuals who continue to 
smoke (Livingston & Lynm. 2012). Quitting smoking before the age of 40 reduces the 
risk of dying from smoking-related disease by about 90% (CDC. 2013).  Many 
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physiologic benefits are associated with smoking cessation. However, the effect of 
smoking cessation in arterial stiffness remains poorly established. Some studies observed 
a decrease in arterial stiffness after acute and chronic smoking cessation (Oren et al. 
2006; Rehill et al. 2006; Yu-Jie et al. 2012), but other studies found that no significant 
change occurred in arterial stiffness after smoking cessation (Polonia et al. 2009; Scallan 
et al. 2010). Therefore, the impact of smoking cessation on arterial stiffness should be 
clarified precisely using the suitable devices and parameters of arterial stiffness in future 
studies. 
Most smokers in the United States stop smoking through a combination of 
behavioral counseling and nicotine replacement therapy, bupropion, or varenicline. 
However, smoking cessation can be challenging because of addiction to the nicotine in 
tobacco (Ussher et al. 2012). In fact, only 6% of smokers can successfully quit smoking 
within a year (Livingston & Lynm. 2012). More effective smoking cessation 
interventions are clearly needed. 
 
2.7 smoking cessation and exercise 
Exercise and physical activity may play a role as an aid to quitting smoking 
adjunct to conventional smoking cessation treatment (e.g. cognitive behavioral therapy, 
nicotine replacement) (Hill et al. 1981). According to the previous study, smokers trying 
to quit are more likely to an active lifestyle than other smokers in most populations 
(Albrecht et al. 1998; Marcus et al. 1995). In fact, it has been observed that physically 
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active individual with smoking who had quit has many general health benefits. In 
addition, exercise has a positive effect on other factors that may prohibit smokers form 
the smoking relapse including perceived coping ability and self-esteem (Ciccolo et al. 
2011). 
Regular exercise may help stop smoking by controlling nicotine withdrawal and 
cravings (Ussher et al. 2012). A previous study found that highly physically active 
smokers exhibited lower nicotine dependence and were observed to have a significant 
increase in smoking cessation attempts (Ward et al. 2003). Additionally, physically active 
smokers had smoked for a shorter duration and smoked fewer cigarettes per day 
(deRuiter et al. 2008). Many studies showed that smokers may be more likely to 
physically active (Ward et al. 2003; deRuiter 2008) and regular exercise can help 
successfully stop smoking (Albrecht et al. 1998), but other studies revealed null effects of 
exercise on smoking cessation (Ussher et al. 2008). It is still unclear whether exercise 
treatments have a positive effect on smoking cessation. Therefore, further studies are 
needed to elucidate the potential role of exercise on smoking cessation in general. 
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CHAPTER 3 
METHODOLOGY 
 
3.1 Subjects 
A total of 78 men (22±5 years) participated in the study. Subjects were assigned 
to groups based on their smoking habit and reported physical activity; sedentary non-
smokers (n=20), sedentary smokers (n=12), physically active non-smokers (n=21), and 
physically active smokers (n=25). Smokers had been smoking at least 8 to 10 cigarettes 
per day for at least 2 years preceding the study.  For at least the previous six months, the 
subjects had been either sedentary (no regular physically activity) or physically active (≥2 
h/week of aerobic exercise).  Exclusion criteria were: established obesity (body mass 
index ≥30 kg/m2), hypertension (systolic >140 mmHg and / or diastolic >90 mmHg), and 
overt cardiovascular disease or other chronic diseases as assessed by the medical history 
questionnaire. 
All experimental procedures were explained to the individuals, and subjects were 
informed of the potential risks of the study, and were given written informed consents to 
participate. All procedures were approved by the Institutional Review Board at the 
University of Texas at Austin. 
 
 18 
3.2 Experimental Procedures 
Subjects reported to the laboratory in the morning having refrained from alcoholic 
beverages, caffeine, food, and smoking for at least 4 hours prior to the experiments. All 
the testing was conducted at the same time of day among the groups. Physically-active 
smokers were studied at least 24 h after their last exercise session to avoid any acute 
effects of exercise while still being representative of their normal physiological state (i.e., 
habitually exercising). Subjects were studied under quiet, comfortable, and ambient 
laboratory (~24oC) conditions. 
Body composition assessment 
Body composition was assessed by a dual-energy x-ray absorptiometry (Lunar 
DPX, GE Medical Systems, Fairfield, CT). During the body composition test, 
participants laid in the supine position on a table for the scan. 
Blood pressure 
Blood pressure was measured with an automatic device (VP-1000, Omron 
Healthcare, Lake Forest, IL) in duplicate on the right arm after five minutes in the upright 
seated position with the arm at heart level. 
Arterial stiffness 
A measure of arterial stiffness, pulse wave velocity, was determined using the 
automated vascular screening device (VP-1000, Omron Healthcare, Lake Forest, IL) as 
previously described (Cortez-Cooper et al. 2005). This device simultaneously measured 
multi-segmental pulse wave velocities for various segments. The pulse wave transit time 
is the time delay between the proximal and distal pulse wave, as determined by the foot-
to-foot method. 
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Maximal oxygen consumption 
All participants performed exercise testing on a treadmill in order to determine the 
maximal aerobic capacity via a modified Bruce protocol. Expired gases were sampled 
continuously via a mixing chamber and analyzed for the concentration of O2 and CO2 
(Physio Dyne, Physio Dyne Inc., Quogue, NY, USA). 
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3.3 Statistical analysis 
Group differences for variables were performed using ANOVA. If a significant F-
value was shown, post-hoc test (LSD) was used to determine significant differences 
among groups. All data are represented as mean±SEM. A significant level of ɑ<0.05 was 
used to determine statistical difference. IBM SPSS version 22 was used for all the 
statistical analyses. 
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CHAPTER 4  
RESULTS 
 
4.1 Selected physical characteristics, blood pressure, and PWV 
Selected physical characteristics of the subjects are shown in Table 1. The 
smokers were slightly older and greater in body mass and BMI than the nonsmokers. As 
expected, both physically active groups had significantly greater VO2max than their 
sedentary peers (P<0.05). The smoking history of pack-years was not different between 
sedentary and active smokers. 
As shown in Table 2, heart rate at rest was significantly lower in both physically 
active groups than their sedentary counterparts (P<0.05). There were no significant 
differences in brachial or carotid blood pressure among groups. 
Figure 1 illustrates group differences in baPWV and augmentation index among 4 
groups.  baPWV was significantly elevated in sedentary smokers compared with the 
other groups.  There was no significant group difference between active non-smokers 
and active smokers.  Augmentation index was greater in sedentary groups than in 
physically active groups. 
 22 
Table 1. Selected subject characteristics in 4 groups 
 
Sedentary  
non-smokers (20) 
Sedentary 
smokers (12) 
Active  
non-smokers (21) 
Active  
smokers (25) 
Age (yr) 22±1 26±2* 21±0† 23±1‡ 
Height (cm) 170±1 173±2 172±1 172±1 
Body mass (kg) 64±3 73±3* 65±1† 70±2* 
BMI (kg/m2) 22±1 24±1* 22±0† 24±1 
Body fat (%) 23±2 25±3 18±1 22±2 
VO2max (ml/kg/min) 39±2 35±2 52±1*† 46±2*†‡ 
Smoking history 
(pack years) 
0±0 9±5 0±0 5±1 
Data are means±SEM; * P<0.05 vs. sedentary non-smokers; † P<0.05 vs. sedentary smokers; ‡ P<0.05 vs. active non-smokers. BMI=body 
mass index, VO2max=maximal oxygen consumption. 
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Table 2. Heart rate and blood pressure at rest in 4 groups  
 
Sedentary  
non-smokers (20) 
Sedentary 
 smokers (12) 
Active  
non-smokers (21) 
Active  
smokers (25) 
Heart rate (bpm) 68±3 65±3 55±2*† 53±1*† 
Brachial Systolic BP (mmHg) 115±2 118±3 118±2 117±2 
Brachial Diastolic BP (mmHg) 66±2 67±2 66±2 67±1 
Brachial Mean BP (mmHg) 84±2 84±2 83±3 86±1 
Carotid Systolic BP (mmHg) 98±1 103±3 104±2 105±3 
Carotid Pulse Pressure (mmHg) 36±2 36±3 35±2 38±2 
Data are means±SEM; * P<0.05 vs. sedentary non-smokers; † P<0.05 vs. sedentary smokers. BP=blood pressure.
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Figure 1: Bar graph of brachial-ankle PWV at rest is compared among sedentary non-
smokers, sedentary smokers, active non-smokers, and active smokers by analysis of 
variance: Data are means±SEM; * P<0.05 vs. sedentary non-smokers; † P<0.05 vs. 
sedentary smokers. 
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CHAPTER 5 
DISCUSSION 
 
The present cross-sectional study was conducted to investigate the influence of 
habitual aerobic exercise on mitigating the smoking-induced arterial stiffening. Our 
findings indicate that chronic smoking elevates arterial stiffness in sedentary individuals 
but that smoking-induced arterial stiffening was absent in chronic smokers who engage in 
regular physical activity. To the best of our knowledge, this is the first study to indicate 
that habitual aerobic exercise can favorably oppose the smoking-associated deterioration 
in vascular stiffness. 
Smoking can lead to the initiation and progression of atherosclerosis and other 
vascular diseases (Doonan et al. 2011).  Arterial stiffness may be one of the mechanisms 
underlying the smoking-related vascular disease.  In the present study, arterial stiffness 
as measured by baPWV was significantly elevated in sedentary smokers compared with 
non-smoking peers.  The present finding is consistent with previous studies showing the 
arterial stiffening effects of cigarette smoking (Mahmud et al. 2003; Kim et al. 2005; 
Rhee et al. 2007).  But this was observed in young healthy subjects in the present study. 
There is no question that the most important strategy for improving 
cardiovascular health in smokers should be smoking cessation (USDHHS. 2014; Jatoi et 
al. 2007).  However, sustained smoking cessation is very difficult to achieve due 
primarily to the addictive nature of nicotine (Ussher et al. 2012).  Thus, interventions 
targeted for reducing or minimizing smoking-induced cardiovascular harm are needed.  
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In this context, physical activity may be a cost-effective harm reduction strategy for those 
who cannot use or afford medications or who cannot access traditional therapeutic 
choices (e.g., pregnant smokers) (Deruiter and Faulkner. 2006).  Considering the 
multitude of benefits induced by regular exercise, it seems logical that the detrimental 
effects of cigarette smoking on vascular function could be antagonized through 
participation in regular physical activity.  We found that baPWV of smokers who are 
physically active is not different from sedentary and active non-smokers.  This was also 
observed in carotid augmentation index, a measure of arterial wave reflection and arterial 
stiffness.  The epidemiological report that smokers who habitually exercise exhibit a 
lower relative risk for CVD than their sedentary peers (Ferrucci et al. 1999) is consistent 
with these findings.  Taken together, these results suggest that regular aerobic exercise 
may be an important lifestyle modification for chronic smokers who attempt to reduce 
cardiovascular harm.  
Skepticism over whether smokers will actually adopt regular physical activity is 
justifiable.  In contrast to the prevalent thought, however, the proportion of chronic 
smokers who perform regular physical activity is fairly high.  In the Canadian 
Community Health Survey, physically active smokers represented almost one quarter of 
the entire smoking population (Deruiter et al. 2008).  These data suggest that a large 
proportion of the daily smoking population possess the motivation and willingness to 
make a deliberate effort to engage in physical activity and that any concerns regarding the 
practicality of prescribing physical activity as a smoking harm reduction therapy are 
unwarranted.  Indeed, smoking has not been shown to be a barrier to participating in 
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regular physical activity (Crombie et al. 2004), and chronic smokers are capable of 
becoming more physically active (Ussher et al. 2008), and the exercise adherence of 
smokers with exercise intervention are comparable to that of non-smokers (Ussher et al. 
2000).  Interestingly, compared with their inactive peers, a greater proportion of 
physically active smokers had tried to quit smoking but failed (Deruiter et al. 2008).  
Collectively, these observations make the results of our present study clinically relevant.     
Arterial stiffness is determined by the intrinsic properties of the arterial wall and 
may be improved by alterations in the contractile states of the vascular smooth muscle 
tone (Tanaka and Safar. 2005).  In apparently healthy older adults, a reduction in alpha-
adrenergic receptor-mediated vascular tone contributes to the decrease in arterial stiffness 
with endurance training (Sugawara et al. 2009).  It is feasible to hypothesize that the 
similar physiological mechanism may act on the arterial wall of chronic smokers.  
Indeed we have previously reported that smokers who habitually perform physical 
activity demonstrate greater levels of peripheral blood flow and peripheral vascular 
conductance (Anton et al. 2006). 
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CHAPTER 6 
LIMITATIONS AND IMPLICATIONS 
 
There are several limitations in the present study that should be noted. First, as we 
used the cross-sectional study design to address the stated aim, the cause-and effect 
relation cannot be determined.  Second, the sample size was relatively small.  Third, 
groups were not matched for some characteristics as there were significant differences in 
age and body mass.  However, these differences were fairly mild. 
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CHAPTER 7 
CONCLUSION 
 
In conclusion, the present study demonstrated that chronic smokers who 
habitually engage in aerobic exercise had lower arterial stiffness compared with 
sedentary smokers.  These results suggest that regular participation in physical activity 
may mitigate smoking-induced arterial stiffening. Interventional studies are needed to 
confirm the present findings obtained using the cross-sectional approach. 
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Appendix A: Informed consent form 
Title of Research Study: Tobacco Smoking, Regular Exercise, and Arterial Stiffness 
 
You are being invited to voluntarily participate in the above-titled research project 
conducted under the directions of Hirofumi Tanaka, Ph.D., Alazne Anton and Miriam 
Cortez-Cooper in the University of Texas’s Department of Kinesiology and Health 
Education. This form provides you with information about the study. The Principal 
Investigator (the person in charge of this research) or his/her representative will 
provide you with a copy of this form to keep for your reference, and will also 
describe this study to you and answer all of your questions. Please read the 
information below and ask questions about anything you don’t understand before 
deciding whether or not to take part. Your participation is entirely voluntary and you 
can refuse to participate without penalty or loss of benefits to which you are 
otherwise entitled. 
 
What is the purpose of this study?   
The purpose of this study is to determine if regular exercise reduces adverse effects 
associated with tobacco smoking on arterial function. This study is a part of our 
ongoing research project assessing the influence of lifestyle factors on cardiovascular 
function. You are being asked to participate in the study because you are one of the 
smoking or non-smoking men and women aged18-75 years. If you participate, you 
will be one of approximately 45 people in the study. 
 
What will be done if you take part in this research study?    
If you decide to participate, you will be asked to participate in research testing over a 
3-week period of time. This will include 4 experimental sessions that require you to 
come to our laboratory 4 different times. During each testing session, which will last 
between 1.5 to 2.5 hours, several measurements described below will be made on 
you. If you are a smoker, you will be asked to come in one additional time. In this 
extra session, you will be asked to smoke a cigarette outside of the building. After 
that we will make some of the measurements (your blood pressure and stiffness of 
artery) in the laboratory described below. All the measurements described below will 
be conducted in the Cardiovascular Aging Research Laboratory in Bellmont Hall. 
 Your heart and blood pressure response to exercise will be evaluated during a 
treadmill stress test if you are over 45 years of age for men and over 55 years 
of age for women. You will be asked to walk on the treadmill for 10 to 12 
minutes while we closely monitor your heart rate and blood pressure. If any 
abnormalities in response to the test are discovered, you will be referred to 
your primary care physician for further testing, and you may be ineligible to 
participate in the study; 
 31 
 Your blood pressure will be measured non-invasively ⅰ) by the arm cuff 
technique (as in your Doctor’s office) and by the finger cuff technique, ⅱ) 
by placing a pencil-like probe over the carotid (neck) artery; 
 Your heart rate will be measured non-invasively using electrocardiography; 
 Your body fat percentage will be measured non-invasively by skinfold 
thickness and dual energy X-ray absorptiometry (DEXA). This DEXA test 
involves you lying on a padded table while a small probe that emits energy to 
measure tissue density passes over your body; 
 Your maximal oxygen consumption (an index of aerobic fitness) will be 
measured during a graded exercise test to exhaustion on a treadmill. During 
the test, the grade (slope) of the treadmill will be increased gradually. We will 
collect your expired air through a mouthpiece; 
 Your blood cholesterol and fat levels will be determined by taking small 
blood samples (2 teaspoons) from a venous catheter (small plastic tube); 
 Stiffness of your artery will be measured non-invasively by ⅰ) placing a 
probe of an ultrasound machine (the same machine that is used to evaluate the 
development of the baby during pregnancy) on the skin of the carotid (neck), 
femoral (hip joint), and wrist arteries; and ⅱ)placing two pencil-like probes 
over various arteries (carotid, femoral, brachial, wrist, and ankle arteries); 
 Your heart structure and function will be measured non-invasively by placing 
a probe of an ultrasound machine on the chest; 
 Manipulation of blood pressure regulating system will be induced by 
squeezing a gripping device with a hand (handgrip exercise) and placing a 
foot in ice cold water for 2 minutes; 
 Your resting metabolic rate will be measured in the morning after you lie 
down quietly on a bed for about 45 minutes while expired air is collected in a 
hood placed over the head and shoulders. 
  
What are the possible discomforts and risks? 
Every effort has been made by the investigators to keep the risk and discomfort 
involved in this study to a minimum. You will be carefully screened at the beginning 
of this study to determine whether you can participate safely. Nevertheless, the 
potential risks associated with this study include 1) a very slight chance of irregular 
heart beat occurring during treadmill exercise, which could lead to fainting and heart 
attack (less than 1% of all subjects); 2) a slight risk of fainting, bruising, or infection 
associated with the dual energy X-ray absorptiometry which is 1/20 of the average X-
ray; and 5) potential psychological and emotional risks for you and your family 
members in response to the results of genetic tests. 
 
What are the possible benefits to you or to others?   
We expect the project to benefit you in the following ways; 1) medical information 
derived from a medical history, physical examination, blood pressure readings, and 
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physician-supervised graded exercise test(if applicable) free of charge; 2) 
measurement of aerobic fitness and body fat percentage free of charge; 3) 
measurement of blood cholesterol levels free of charge; and 4) contribution to 
scientific knowledge that is likely to result in the documentation of a benefit that 
could significantly reduce the risk of cardiovascular disease in the documentation of a 
benefit that could significantly reduce the risk of cardiovascular disease in men and 
women.   
 
If you choose to take part in this study, will it cost you anything?   
No 
 
Will you receive compensation for your participation in this study?   
You will receive our laboratory t-shirt and monetary compensation of $50. If you 
decide to drop out in the middle of the study, the payment to you will be prorated.    
 
What if you are injured because of the study?   
The University has no facilities or insurance to cover research-related injuries. UT 
student participants will be afforded access to the designated services available to all 
students through the University of Texas Student Health Center. Other research 
participants are not covered. No treatment will be provided for research related injury 
and no payment can be provided in the event of a medical problem. 
 
If you do not want to take part in this study, what other options are available to 
you?   
Your participation in this study is entirely voluntary.  You are free to refuse to be in 
the study, and your refusal will not influence current or future relationships with The 
University of Texas at Austin. 
 
How can you withdraw from this research study and who should you call if you 
have questions? 
If you wish to stop your participation in this research study for any reason, you should 
contact the principal investigator: Alazne Anton at (512) 471 - 8594.  You should also 
call the principal investigator for any questions, concerns, or complaints about the 
research.  You are free to withdraw your consent and stop participation in this research 
study at any time without penalty or loss of benefits for which you may be entitled. 
Throughout the study, the researchers will notify you of new information that may 
become available and that might affect your decision to remain in the study.  
 
Whom to contact with questions concerning your rights as a research participant? 
For questions about your rights or any dissatisfaction with any part of this study, you 
can contact, anonymously if you wish, the Institutional Review Board by phone at 
(512) 471-8871 or email at orsc@uts.cc.utexas.edu. 
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How will your privacy and the confidentiality of your research records be 
protected? 
Your privacy and the confidentiality of your data will be protected by identification 
number, not with your name, and will be kept in a locked file cabinet located in the 
Cardiovascular Aging Research Laboratory. Your blood sample will be stored for 10 
years and then disposed of properly according to the University guidelines.  
 
 
Will the researchers benefit from your participation in this study? 
The researchers will gain no benefit from your participation in this study beyond the 
publication and/or presentation of the results obtained from the study.  
 
Signatures:   
 
As a representative of this study, I have explained the purpose, the procedures, the 
benefits, and the risks that are involved in this research study: 
 
 
 
                                                                        
Signature and printed name of person obtaining consent     Date 
 
 
You have been informed about this study’s purpose, procedures, possible benefits 
and risks, and you have received a copy of this form. You have been given the 
opportunity to ask questions before you sign, and you have been told that you can 
ask other questions at any time. You voluntarily agree to participate in this study.  
By signing this form, you are not waiving any of your legal rights. 
 
 
 
 
Printed Name of Subject                                 Date 
 
 
 
 
Signature of Subject                                     Date 
 
 
 
 
Signature of Principal Investigator                         Date  
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Appendix B: Health research questionnaire 
 
Personal Information 
Today’s Date ______________ Please print your name __________________________ 
Phone Number __________________  Email __________________________________ 
Date of Birth ____________ Age ______               Sex      □ Male   
□ Female 
Who is your physician? ______________________   Phone ______________________ 
In case of emergency, contact _________________   Phone ______________________ 
 
Please circle the highest grade in school you have completed: 
Elementary school 1 2 3 4 5 6 7 8 
High school  9 10 11 12 
College/Post Grad 13 14 15 16 17 18 19 20+ 
 
What is your martial status?    □Single     □Married;   □ Widowed    
□Divorced; Separated 
Ethnic Background:    □Hispanic or Latino      □Not Hispanic or Latino 
Race: 
□White         □American Indian/Alaskan Native 
 □Pacific Islander 
□Black or African American  □Asian 
       
Symptoms or Signs Suggestive of Disease 
Check appropriate box:    
Yes No   
□ □ 1. Have you experienced unusual pain or discomfort in your cheek, neck, 
jaw, arms or other areas that may be due to heart problems? 
□ □ 2. Have you experienced unusual fatigue or shortness of breath at rest, 
during usual activities, or during mild-to-moderate exercise (e.g., 
climbing stairs, carrying groceries, brisk walking, cycling)? 
□ □ 3. When you stand up, or sometimes during the night while you are 
sleeping, do you have difficulty breathing? 
□ □ 4. Do you lose your balance because of dizziness or do you ever lose 
consciousness? 
□ □ 5. Do you suffer from swelling of the ankles (ankle edema)? 
□ □ 6. Have you experienced an unusual and rapid throbbing or fluttering of the 
heart? 
□ □ 7. Have you experienced severe pain in your leg muscles during walking? 
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□ □ 8. Has a doctor told you that you have a heart murmur? 
 
Chronic Disease Risk Factors 
Check appropriate box: 
 
Yes No   
□ □ 9a. Are you a male over age 45 years or a female over age 55 years? 
□ □  b. Are you a female who has experienced premature menopause? 
□ □  c. If you answered “yes” to 9b, are you on estrogen replacement 
therapy? 
□ □ 10. Has your father or brother had a heart attack or died suddenly of heart 
disease before the age of 55; has your mother or sister experienced these 
heart problems before the age of 65? 
Yes No   
□ □ 11. Are you a current cigarette smoker? 
□ □ 12. Has a doctor told you that you have high blood pressure (more than 
140/90 mm Hg) or a heart condition? 
□ □ 13. Is your total serum cholesterol greater than 200 mg/dl, or has a doctor 
told you that your cholesterol is at a high risk-level? 
□ □ 14. Do you have diabetes mellitus? 
□ □ 15. Are you physically inactive and sedentary (little physical activity on the 
job or during leisure time)? 
□ □ 16. Do you have a bone or joint problem that could be made worse by a 
change in your physical activity? 
□ □ 17. During the past year, would you say that you have experienced enough 
stress, strain, and pressure to have a significant effect on your health? 
□ □ 18. Do you eat foods nearly every day that are high in fat and cholesterol 
such as fatty meats, cheese, fried foods, butter, whole milk, or eggs? 
□ □ 19. Do you weigh 30 or more pounds than you should? 
□ □ 20. Do you know of any other reason you should not do physical activity? 
 
Medical History 
21. Please check which of the following conditions you have had or now have.  Also 
check medical conditions in your family (father, mother, brother(s), or sister(s)).  Check 
as many as apply. 
 
Self Family Medical Condition  Self Family Medical Condition 
□ □ Coronary heart disease, 
heart attack; by-pass 
surgery 
 □ □ Major injury/fracture 
to foot, leg, knee 
□ □ Arrhythmias  □ □ Major injury to back 
or neck 
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□ □ Angina  □ □ Major injury/fracture to 
hip or shoulder 
□ □ High blood pressure  □ □ Rheumatoid Arthritis 
□ □ Peripheral vascular 
disease 
 □ □ Osteoarthritis 
□ □ Phlebitis or emboli  □ □ Gout 
□ □ Other heart problems  □ □ Osteoporosis 
□ □ Stroke  □ □ Fibromyalgia 
□ □ Asthma  □ □ Diabetes mellitus 
□ □ Bronchitis  □ □ Kidney disease 
□ □ COPD (emphysema)  □ □ Cataracts 
□ □ Lung cancer  □ □ Glaucoma 
□ □ Breast cancer  □ □ Hearing loss 
□ □ Prostate cancer  □ □ Depression 
□ □ Skin cancer  □ □ Anxiety, phobias 
□ □ Colorectal cancer  □ □ Eating disorders  
□ □ Other cancer.  Specify:  □ □ Sleeping problems 
□ □ Gallstones/gallbladder 
disease 
 □ □ Substance abuse 
problems (alcohol, other 
drugs, etc.) 
□ □ Liver disease (cirrhosis)  □ □ Chronic Fatigue 
Syndrome 
□ □ Hepatitis   □ □ Thyroid problems 
□ □ Anemia (low iron)   □ □ Hysterectomy 
□ □ Stomach/duodenal ulcer  □ □ Problems with 
menstruation 
□ □ Rectal growth or bleeding  □ □ Post-menopausal (date:      
) 
□ □ Crohne’s disease  □ □ Raynaud’s disease 
□ □ Irritable bowel syndrome  □ □ Allergies 
□ □ Marfan’s syndrome     
 
Any other health problems.  Please specify and include information on any recent 
illnesses, hospitalizations, or surgical procedures. 
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22. Please check any of the following medications you take regularly and give the name 
of the medication. 
Medication    Name of Medication 
□ Heart medicine   ______________________________________ 
□ Blood pressure medicine  ______________________________________ 
□ Blood cholesterol medicine  ______________________________________ 
□ Hormones    ______________________________________ 
□ Birth control medicine  ______________________________________ 
□ Medicine for breathing/lungs ______________________________________ 
□ Insulin    ______________________________________ 
□ Other medicine for diabetes ______________________________________ 
□ Arthritis medicine   ______________________________________ 
□ Medicine for depression  ______________________________________ 
□ Medicine for anxiety  ______________________________________ 
□ Thyroid medicine   ______________________________________ 
□ Medicine for ulcers   ______________________________________ 
□ Painkiller medicine   ______________________________________ 
□ Allergy medicine   ______________________________________ 
□ Other (please specify)  ______________________________________ 
□ Do you have any drug allergies? ______________________________________ 
□ Dietary supplements (please specify)  ____________________________________ 
 
Body Weight 
23. What is the most you have ever weighed? ______________ pounds 
24. Are you now trying to: 
□ Lose weight  □ Gain weight  □ Stay about the same       □ Not trying 
to do anything 
 
Stress 
25. During the past month, how would you rate your overall level of stress? 
□ Very high  □ High  □ Moderate  □ Low 
26. In the past year, how much effect has stress had on your health? 
□ A lot   □ Some  □ Hardly any or none 
27. On average, how many hours of sleep do you get in a 24-hour period? 
□ Less than 5  □ 5-6.9 □ 7-9  □ More than 9 
 
Substance Use 
28. How would you describe your cigarette smoking habits? 
□ Never smoked 
□ Used to smoke.  How many years has it been since you smoked?  _______ years 
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□ Still smoke.  How many cigarettes a day do you smoke on average? 
___cigarettes/day 
 
29. How many alcoholic drinks do you consume? (A “drink” is a glass of wine, a wine 
cooler, a 16oz bottle/12oz can of beer, a shot glass of liquor, or a mixed drink). 
□ Never use alcohol  □ Less than 1 per week □ 1-6 per week
 □ 1 per day 
□ 2-3 per day   □ More than 3 per day 
 
30. In one sitting, how many drinks do you typically consume?  
____________________ 
31. How many cups (8 ounces) of coffee do you drink per day? ____________________ 
32.  How many ounces of sodas containing caffeine do you drink per day? ___________ 
 
Physical Fitness, Physical Activity/Exercise 
33. Considering a 7-Day period (a week), how many times on the average do you do the 
following kinds of exercise for more than 15 minutes during your free time (write on 
each line the appropriate number). 
 
a)  STRENUOUS EXERCISE (HEART BEATS RAPIDLY)    Times Per Week 
     (i.e. running, jogging, hockey, football, soccer, squash, basketball, 
     cross country skiing, judo, roller skating, vigorous swimming,   ______________ 
     vigorous long distance bicycling) 
 
b) MODERATE EXERCISE (NOT EXHAUSTING)   
 (i.e. fast walking, baseball, tennis, easy bicycling, volleyball, 
 badminton, easy swimming, alpine skiing, popular and folk dancing) 
 _____________ 
 
c) MILD EXERCISE (MINIMAL EFFORT) 
 (i.e. yoga, archery, fishing from river bank, bowling, horseshoes, golf, 
 snow-mobiling, easy walking)      
 _____________ 
  
34. Considering a 7-Day period (a week), during your leisure-time, how often do you 
engage in any regular activity long enough to work up a sweat (heart beats rapidly) 
 
   □ OFTEN  □ SOMETIMES □ NEVER/RARELY 
 
35. How long have you exercised or played sports regularly? 
 □ I do not exercise regularly □ Less than 1 year □ 1-2 years 
□ 2-5 years            □ 5-10 years         □ More than 10 years 
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Occupational Health 
 
36. Please describe your main job title and duties. 
 
______________________________________________________________________ 
 
37. How much hard physical work is required on your job? 
□ A great deal  □A moderate amount  □A little  □ 
None 
 
 
Reproductive Health 
38. What is the date of your last menstrual cycle? 
 
             
 
X-ray testing 
39. Have you recently had or are you planning to have barium tests or a nuclear medicine 
scan or injection with an x-ray dye?  
□ No            □ Yes      If yes, when?       
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Appendix C: Smoking Questionnaire 
Smokers 
     Cigarettes 
   1 Do you smoke cigarettes? If yes, continue………………………………….  yes       no 
   2 What brand of cigarette do you smoke?         _____________________ 
   3 How many cigarettes do you smoke each day?        _____________________ 
   4 How many years have you smoked this number of cigarettes each day? _____________ 
   5 Before that time, how many cigarettes did you smoke/day?   _____________________ 
Ownrolled cigarettes 
6 Do you smoke ownrolled cigarettes? If yes, continue……………………    yes       no 
   7 How many packages of tobacco (40 grams) do you use each week? ___________________ 
8 How many years have you used this number of packages/wk?   _____________________ 
9 Before that time, how many packages did you use/wk?         _____________________ 
Cigars/cigarillos 
10 Do you smoke cigars or cigarillos? If yes, continue……………….         yes       no 
11 How many cigars/cigarillos do you smoke each week?         _____________________ 
12 How many years have you smoked this number of cigars/cigarillos each week? __________ 
13 Before that time, how many cigars/cigarillos did you smoke/wk? ___________ 
Pipe tobacco 
14 Do you smoke pipe tobacco? If yes, continue………….………….         yes       no 
15 How many packages of pipe tobacco (50 grams) do you use each week? _______________ 
16 How many years have you smoked this number of packages each week? _______________ 
17 Before that time, how many packages of pipe tobacco did you smoke each week? ________ 
Smoking History 
18 How old were you when you first started smoking? _____________________ 
19 Have you ever tried to quit smoking from the moment you started to smoke regularly? ____ 
20 If yes, how many times did you quit smoking? _____________________ 
21 How long did these attempts last on average?  _____________________ 
22 How old were you when you tried to quit smoking for the first time? _________________ 
23 How old were you when you tried to quit smoking for the last time? _________________ 
Non-Smokers 
24 Have you ever smoked? If yes, continue…………………………          yes       no 
25 How many cigarettes did you smoke each day on average? _____________________ 
26 How many years did you smoke this number of cigarettes? _____________________ 
27 How many packages of ownrolled tobacco did you smoke each week on average? _______ 
28 How many years did you smoke this number of packages? _____________________ 
29 How many cigars/cigarillos did you smoke each week on average? ______________ 
30 How many years did you smoke this number of cigars/cigarillos on average? ____________ 
31 How many packages of pipe tobacco did you smoke each week on average? ____________ 
32 How many years did you smoke this number of packages? ____________ 
33 How old were you when you first stared smoking? ____________ 
34 How old were you when you quit smoking for the last time? ____________ 
35 How many times did you quit before? ___________ 
36 How long did these attempts last on average? _________ 
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Appendix D: Physical activity during one week 
 
Can you describe your regular physical activity during one week? Please, describe the duration of 
activity and the intensity. 
 
 
 Intensity Duration (Time) Activity 
Monday    
Tuesday    
Wednesday    
Thursday    
Friday    
Saturday    
Sunday    
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Appendix E: General questionnaire 
 
SCREENING STUDY 
     GENERAL DATA 
     Name: _________________________   Date of Birth: ____________________   
Age: ____________ 
 
     Email Address: 
______________________________________________________________________ 
 
     Address: 
______________________________________________________________________ 
 
     Phone Number: Home  ____________          Cell Phone: _____________ 
      
     Occupation: __________           When are you available for the test: ____ 
Cigarette Smoking, Regular Exercise and Arterial Functions                                             Phone: (512) 
471-8594 
 
 
     GENERAL HEALTH HISTORY 
     Height: ____________   Weight: ____________ 
     What is your: 
       Blodd pressure? ____________         
Cardiovascular disease? ___________ 
       Diabetes? _________________         
Medication? ____________________ 
       Total Cholesterol? _________         
LDL Cholesterol? ________________ 
       Hormone replacement? ___________   
Do you participate in regular exercise? ___________________ 
       Do you smoking? ____________________        
Cigarette per day? ___________________ 
       # years smoking? ____________________ 
Cigarette Smoking, Regular Exercise and Arterial Functions                                             Phone: (512) 
471-8594 
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Appendix F: Godin Leisure-Time Exercise Questionnaire 
 
INSTRUCTIONS 
 
In this excerpt from the Godin Leisure-Time Exercise Questionnaire, the individual is asked to 
complete a self-explanatory, brief four-item query of usual leisure-time exercise habits. 
 
CALCULATIONS 
 
For the first question, weekly frequencies of strenuous, moderate, and light activities are 
multiplied by nine, five, and three, respectively. Total weekly leisure activity is calculated in 
arbitrary units by summing the products of the separate components, as shown in the following 
formula: 
 
 Weekly leisure activity score = (9  Strenuous) + (5  Moderate) + (3  Light) 
 
 The second question is used to calculate the frequency of weekly leisure-time activities pursued 
“long enough to work up a sweat“ (see questionnaire). 
 
EXAMPLE 
 
Strenuous = 3 times/wk 
 
Moderate = 6 times/wk 
 
Light = 14 times/wk 
 
Total leisure activity score = (9  3) + (5  6) + (3  14) = 27 + 30 + 42 = 99 
 
GODIN LEISURE-TIME EXERCISE QUESTIONNAIRE 
 
1. During a typical 7-Day period (a week), how many times on the average do you do the 
following kinds of exercise for more than 15 minutes during your free time (write on 
each line the appropriate number). 
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Times Per 
Week 
a) STRENUOUS EXERCISE 
 (HEART BEATS RAPIDLY) __________ 
 (e.g., running, jogging, hockey, football, soccer, 
 squash, basketball, cross country skiing, judo, 
 roller skating, vigorous swimming, 
  vigorous long distance bicycling) 
 
 
 MODERATE EXERCISE 
 (NOT EXHAUSTING) __________ 
 (e.g., fast walking, baseball, tennis, easy bicycling, 
 volleyball, badminton, easy swimming, alpine skiing, 
 popular and folk dancing) 
 
b) MILD EXERCISE 
 (MINIMAL EFFORT) __________ 
 (e.g., yoga, archery, fishing from river bank, bowling, 
 horseshoes, golf, snow-mobiling, easy walking) 
 
 
2. During a typical 7-Day period (a week), in your leisure time, how often do you engage in 
any regular activity long enough to work up a sweat (heart beats rapidly)? 
 
 OFTEN  SOMETIMES  NEVER/RARELY 
 1. |_| 2. |_| 3. |_| 
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